Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -4.44% is in line with its 1-year average of -4.51%, around the middle of its 1-year range (-5.90%–-2.86%).
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2.86%.
OPERATING MARGIN
-4.44%
OPERATING MARGIN AVG TTM
N/A
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Starling Oncology, Inc.
Market Cap
$658.53M
Operating Margin
-4.44%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$654.74M
Operating Margin
-4498.06%
TTM Avg
-5642.71%
3Y Avg
-2821.36%
5Y Avg
-1883.89%
Market Cap
$662.48M
Operating Margin
15.26%
TTM Avg
16.07%
3Y Avg
9.54%
5Y Avg
2.83%
Market Cap
$665.48M
Operating Margin
-187.24%
TTM Avg
-253932.81%
3Y Avg
-127981.70%
5Y Avg
-85456.42%
Market Cap
$665.98M
Operating Margin
317.06%
TTM Avg
-14996.68%
3Y Avg
-12629.31%
5Y Avg
-15360.40%
Market Cap
$680.78M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-328.80%
5Y Avg
-307.62%
Market Cap
$635.62M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$685.85M
Operating Margin
-550.33%
TTM Avg
-849.94%
3Y Avg
-1127.37%
5Y Avg
-1259.40%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Starling Oncology, Inc. (STLN) | $658.53M | -4.44% | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $654.74M | -4498.06% | -5642.71% | -2821.36% | -1883.89% |
| MiMedx Group, Inc. (MDXG)vs › | $662.48M | 15.26% | 16.07% | 9.54% | 2.83% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $665.48M | -187.24% | -253932.81% | -127981.70% | -85456.42% |
| Helus Pharma Inc. (HELP)vs › | $665.98M | 317.06% | -14996.68% | -12629.31% | -15360.40% |
| Annexon, Inc. (ANNX)vs › | $670.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| Solid Biosciences Inc. (SLDB)vs › | $680.78M | 0.00% | 0.00% | -328.80% | -307.62% |
| Aura Biosciences, Inc. (AURA)vs › | $635.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| Verastem, Inc. (VSTM)vs › | $685.85M | -550.33% | -849.94% | -1127.37% | -1259.40% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $689.31M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
15.7%
Operating Margin
-4.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -2.86% |
| 2026-03-31 | -4.42% |
| 2025-12-31 | -4.87% |
| 2025-09-30 | -5.90% |
